Pune, July 22, 2022 (GLOBE NEWSWIRE) — The global bioreactor market size was pegged at ~US$ 2.56 billion in 2021. The market is expected to clock US$ ~9.75 billion by 2030, to grow at a CAGR of ~16.0% between the forecast period. All information is portrayed in the latest report published by Growth Plus Reports. Report Title “Bioreactor Market by Material Type (Glass, Stainless Steel, and Single Use), by Usage (Lab-Scale Production, Pilot-Scale Production, and Full-Scale Production), by End User (Pharmaceuticals and Biopharmaceuticals Manufactures, Contract Research Organization, Academic & Research Institutes, and Others) – Global Outlook & Forecast 2022-2030”
Download Exclusive Sample of Report @ https://growthplusreports.com/inquiry/request-sample/bioreactor-market/7729
Market Driver
In the pharmaceutical industry, the rising demand for therapeutic drugs will drive market revenue. Because of the high prevalence of cancer, there is a growing demand for monoclonal antibodies (mAb). Furthermore, ongoing advancements in bioprocessing equipment, widespread adoption of advanced technologies, and rising demand for single-use bioreactors will drive the market growth.
Coronavirus infection has recently afflicted millions of people worldwide. Global casualties have increased as a result of community transmission in some countries. Biopharmaceutical and biotechnological companies have been intensely focusing their efforts on COVID-19 vaccine research and…
